Re: Merck's PIII Prostate trial, not the one with ZEN-3694, is halted for not showing improvement vs control

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KayakerBC

Rank: Treasurer [?]

Points: 1691 [?]

Votes: 23 Score: 2.6 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Merck's PIII Prostate trial, not the one with ZEN-3694, is halted for not showing improvement vs control

in response to

Merck's PIII Prostate trial, not the one with ZEN-3694, is halted for not showing improvement vs control

Payzone

posted on Jan 26, 2023 01:08PM

From the article, this looks like it could be a concern......

....In addition to failing the primary endpoints, the Keytruda combo group experienced a greater amount of serious adverse events, according to the news release....

1 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply